ACM
SKBI

Ativo Capital Management’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Ativo Capital Management’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-61,837
Closed -$454K – 205
2014
Q2 		$454K Buy
61,837
+1,342
+2% +$8K 0.2% 124
2014
Q1 		$397K Buy
+60,495
New +$306K 0.16% 151

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ativo Capital Management's SKBI Position: Q3 2014 in Review

Ativo Capital Management sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q3 2014, closing a stake of 61,837 shares — an estimated $454K sold.

Ativo Capital Management first reported a position in SKBI in Q1 2014 and held it in 2 quarters. The position peaked at $454K in Q2 2014. 11 funds tracked by Wall St. Rank hold SKBI as of Q3 2014.

  • Ativo Capital Management reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q3 2014 after selling out during the quarter.
  • Ativo Capital Management sold 61,837 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q3 2014, an estimated $454K.
  • Ativo Capital Management first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q1 2014 and held it in 2 quarters.
  • Ativo Capital Management's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $454K in Q2 2014.
  • 11 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q3 2014.

Based on Ativo Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.